OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Programming inflammatory cell death for therapy
Shelbi Christgen, Rebecca E. Tweedell, Thirumala‐Devi Kanneganti
Pharmacology & Therapeutics (2021) Vol. 232, pp. 108010-108010
Open Access | Times Cited: 191

Showing 1-25 of 191 citing articles:

Regulated cell death (RCD) in cancer: key pathways and targeted therapies
Peng Fu, Minru Liao, Rui Qin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 456

The interaction between ferroptosis and inflammatory signaling pathways
Yue Chen, Zemin Fang, Xin Yi, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 196

Advances in mechanism and regulation of PANoptosis: Prospects in disease treatment
Peng Zhu, Zhuo-Ran Ke, Jing-Xian Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 91

Apoptosis Regulators Bcl-2 and Caspase-3
Piret Hussar
Encyclopedia (2022) Vol. 2, Iss. 4, pp. 1624-1636
Open Access | Times Cited: 77

PANoptosis: A Cell Death Characterized by Pyroptosis, Apoptosis, and Necroptosis
Chunxia Shi, Pan Cao, Yukun Wang, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 1523-1532
Open Access | Times Cited: 68

Regulated cell death pathways in cardiomyopathy
Shuyuan Sheng, Jiamin Li, Xinyang Hu, et al.
Acta Pharmacologica Sinica (2023) Vol. 44, Iss. 8, pp. 1521-1535
Closed Access | Times Cited: 61

The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
Runzhi Guo, Jiayu Duan, Shaokang Pan, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 42

Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application
Na Liu, Min‐Bin Chen
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116115-116115
Open Access | Times Cited: 40

Recent strategies for evoking immunogenic Pyroptosis in antitumor immunotherapy
Zhangxin He, Dexiang Feng, Chaoji Zhang, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 375-394
Open Access | Times Cited: 15

Membrane-anchoring clickable Iridium(III) nanosonosensitizer in situ evokes PANoptosis for augmented tumor sono-immunotherapy
Xiaoyu Xu, Shayibai Shabiti, Xu Zhang, et al.
Nano Today (2024) Vol. 56, pp. 102270-102270
Closed Access | Times Cited: 14

Cell death: The underlying mechanisms of photodynamic therapy for skin diseases
H.Y. Li, Jingjie Shen, Chunfu Zheng, et al.
Deleted Journal (2025)
Open Access | Times Cited: 1

Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer
Chunmei Zhang, Ning Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 53

Anti‐PANoptosis is involved in neuroprotective effects of melatonin in acute ocular hypertension model
Dan Ye, Yue Xu, Yuxun Shi, et al.
Journal of Pineal Research (2022) Vol. 73, Iss. 4
Closed Access | Times Cited: 53

Regulated cell death in cancer: from pathogenesis to treatment
Linjing Gong, Dong Huang, Yujun Shi, et al.
Chinese Medical Journal (2022) Vol. 136, Iss. 6, pp. 653-665
Open Access | Times Cited: 50

Pyroptosis and degenerative diseases of the elderly
Jiamin Zhou, Jingjing Qiu, Yuwan Song, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 37

Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases
Lian Wang, Yanghui Zhu, Lu Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 35

The Role of the NLRP3 Inflammasome and Programmed Cell Death in Acute Liver Injury
Chaoqun Yu, Peng Chen, Longyu Miao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3067-3067
Open Access | Times Cited: 34

The applications of nanozymes in cancer therapy: based on regulating pyroptosis, ferroptosis and autophagy of tumor cells
Yuan Zhang, Wanpeng Yu, Mengmeng Chen, et al.
Nanoscale (2023) Vol. 15, Iss. 29, pp. 12137-12156
Closed Access | Times Cited: 33

Current evidence and therapeutic implication of PANoptosis in cancer
Dickson Kofi Wiredu Ocansey, Fei Qian, Peipei Cai, et al.
Theranostics (2023) Vol. 14, Iss. 2, pp. 640-661
Open Access | Times Cited: 27

Disulfidptosis-associated LncRNAs index predicts prognosis and chemotherapy drugs sensitivity in cervical cancer
Li Liu, Jun Liu, Qianbao Lyu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 26

The emerging role of PANoptosis in cancer treatment
Yongai Xiong
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115696-115696
Open Access | Times Cited: 23

Ursodeoxycholic acid alleviates sepsis-induced lung injury by blocking PANoptosis via STING pathway
Yu-qiong He, Jiuling Deng, Cancan Zhou, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111161-111161
Closed Access | Times Cited: 22

NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence
Shuman Zhen, Yunlong Jia, Yan Zhao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 13

Glycolysis: an emerging regulator of osteoarthritis
Dingming Jiang, Jianan Guo, Yingquan Liu, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 11

PANoptosis subtypes predict prognosis and immune efficacy in gastric cancer
Zitao Liu, Liang Sun, Xingyu Peng, et al.
APOPTOSIS (2024) Vol. 29, Iss. 5-6, pp. 799-815
Closed Access | Times Cited: 11

Page 1 - Next Page

Scroll to top